CY1112212T1 - NEW VEGETABLE FORMATS OF VOLUME CONNECTED WITH PARTICULARS OF ANTI-HUMAN LEVEL CELLS (HLA) CLASS I OR II - Google Patents
NEW VEGETABLE FORMATS OF VOLUME CONNECTED WITH PARTICULARS OF ANTI-HUMAN LEVEL CELLS (HLA) CLASS I OR IIInfo
- Publication number
- CY1112212T1 CY1112212T1 CY20121100003T CY121100003T CY1112212T1 CY 1112212 T1 CY1112212 T1 CY 1112212T1 CY 20121100003 T CY20121100003 T CY 20121100003T CY 121100003 T CY121100003 T CY 121100003T CY 1112212 T1 CY1112212 T1 CY 1112212T1
- Authority
- CY
- Cyprus
- Prior art keywords
- hla
- class
- particulars
- formats
- level cells
- Prior art date
Links
- 235000013311 vegetables Nutrition 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 208000003174 Brain Neoplasms Diseases 0.000 abstract 1
- 208000032612 Glial tumor Diseases 0.000 abstract 1
- 206010018338 Glioma Diseases 0.000 abstract 1
- 208000008839 Kidney Neoplasms Diseases 0.000 abstract 1
- 206010038389 Renal cancer Diseases 0.000 abstract 1
- 230000001093 anti-cancer Effects 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000002619 cancer immunotherapy Methods 0.000 abstract 1
- 208000005017 glioblastoma Diseases 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000001024 immunotherapeutic effect Effects 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 abstract 1
- 201000010982 kidney cancer Diseases 0.000 abstract 1
- 210000000265 leukocyte Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Η παρούσα εφεύρεση αφορά νέα σκευάσματα πεπτιδίων που σχετίζονται με όγκους τα οποία συνδέονται σε μόρια του αντιγόνου ανθρώπινων λευκοκυττάρων (HLA) Τάξης I ή II ως εμβόλια για χρήση σε ανοσοθεραπευτικές μεθόδους. Συγκεκριμένα, η παρούσα εφεύρεση σχετίζεται με σκευάσματα για την ανοσοθεραπεία του καρκίνου, και συγκεκριμένα καρκίνο του νεφρού και του εγκεφάλου, και συγκεκριμένα γλοίωμα, ειδικότερα γλοιοβλάστωμα καρκίνου. Η παρούσα εφεύρεση αφορά επιπλέον συνθέσεις εμβολίων για να επιφέρουν αντικαρκινικές ανοσοαπαντήσεις.The present invention relates to novel formulations of tumor-associated peptides that bind to Class I or II human leukocyte antigen (HLA) molecules as vaccines for use in immunotherapeutic methods. In particular, the present invention relates to formulations for cancer immunotherapy, in particular kidney and brain cancer, and in particular glioma, in particular glioblastoma of cancer. The present invention relates to further vaccine compositions to induce anti-cancer immune responses.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4766908P | 2008-04-24 | 2008-04-24 | |
| EP08008292A EP2113253B1 (en) | 2008-04-30 | 2008-04-30 | Novel formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules for vaccines |
| EP09005725A EP2111867B1 (en) | 2008-04-24 | 2009-04-23 | Novel formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules for vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1112212T1 true CY1112212T1 (en) | 2015-12-09 |
Family
ID=47785995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20121100003T CY1112212T1 (en) | 2008-04-24 | 2012-01-03 | NEW VEGETABLE FORMATS OF VOLUME CONNECTED WITH PARTICULARS OF ANTI-HUMAN LEVEL CELLS (HLA) CLASS I OR II |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP5921395B2 (en) |
| CY (1) | CY1112212T1 (en) |
| HK (1) | HK1223290A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3868401A1 (en) * | 2020-02-21 | 2021-08-25 | Assistance Publique Hôpitaux de Paris | Optimization of peptide-melanin binding |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2275119T3 (en) * | 1995-07-27 | 2013-11-11 | Genentech Inc | Stable, isotonic lyophilized protein formulation |
| EP1617804A4 (en) * | 2003-04-11 | 2007-07-25 | Antigenics Inc | IMPROVED VACCINES BASED ON THERMAL SHOCK PROTEINS AND IMMUNOTHERAPIES THEREOF |
| AR048098A1 (en) * | 2004-03-15 | 2006-03-29 | Wyeth Corp | CALIQUEAMYCIN CONJUGATES |
| ES2330013T3 (en) * | 2005-09-05 | 2009-12-03 | Immatics Biotechnologies Gmbh | PEPTIDES ASSOCIATED WITH TUMORS UNITED TO MOLECULES OF THE HUMAN LEUCOCITE ANTIGEN (HLA) CLASS I OR II AND RELATED CANCER VACCINES. |
| DE602008000891D1 (en) * | 2008-04-30 | 2010-05-12 | Immatics Biotechnologies Gmbh | Novel formulations of tumor-associated peptides which bind to human leukocyte antigens of class I or II for vaccination |
-
2012
- 2012-01-03 CY CY20121100003T patent/CY1112212T1/en unknown
- 2012-09-12 JP JP2012200596A patent/JP5921395B2/en not_active Expired - Fee Related
-
2016
- 2016-10-05 HK HK16111596.7A patent/HK1223290A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP5921395B2 (en) | 2016-05-24 |
| HK1223290A1 (en) | 2017-07-28 |
| JP2013028621A (en) | 2013-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1110178T1 (en) | NEW VEGETABLE PEPPER CONNECTIONS CONCLUDED IN PARTICULARS OF HLA LEVEL I OR I | |
| CY1119739T1 (en) | Innovative Immunotherapy Against Brain Tumors | |
| CY1118702T1 (en) | COMPOSITION OF VOLUMES CONCERNING VOLUME AND RELATED Cancer Vaccine for Glioblastoma Therapy (GLIOBLASTOMA, GBM) | |
| CY1115999T1 (en) | NEW AND POWERFUL MHC-CATEGORY II PURPOSES FROM SURBIVIN AND NEUROCANE | |
| CY1121691T1 (en) | PERSONALIZED IMMUNOTHERAPY AGAINST NEURON AND BRAIN TUMORS | |
| CY1113062T1 (en) | TUMORS RELATED TO TUMORS CONNECTED WITH PARTICULARS OF HUMAN LEVEL CELLS (HLA) CLASS I OR II AND RELATED ANTIQUES | |
| CY1110051T1 (en) | TUMORS RELATED TO TUMORS CONNECTED IN PARTICULARS OF THE HLA CLASS II ANTI-HUMAN ANTIGEN | |
| CY1119941T1 (en) | STABLE AND SOLUBLE PARTS | |
| CY1117115T1 (en) | Innovative Immunotherapy Against Tumors And Neurons Of The Brain | |
| CY1124847T1 (en) | NOVEL PEPTIDES AND PEPTIDE COMBINATIONS FOR USE IN IMMUNOTHERAPY AGAINST HEPATO CELL CARCINOMA (HCC) AND OTHER CANCER | |
| UA104572C2 (en) | Novel formulations of tumour-associated peptides binding to human leukocyte antigen (hla) class i or ii molecules for vaccines | |
| CY1112212T1 (en) | NEW VEGETABLE FORMATS OF VOLUME CONNECTED WITH PARTICULARS OF ANTI-HUMAN LEVEL CELLS (HLA) CLASS I OR II | |
| DK2170941T3 (en) | Pre-procalcitonin antigen T epitopes | |
| CY1116819T1 (en) | Innovative Immunotherapy Against Different Tumors Including Gastrointestinal and Gastric Cancer |